XML 79 R68.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segment Information - Schedule of Segment Reporting Information, by Segment (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenue:        
Total revenue $ 56,206 $ 80,568 $ 94,150 $ 161,270
Segment research and development expense:        
Total segment research and development expense 134,221 144,282 270,678 306,921
Segment general and administrative expense:        
Total segment general and administrative expense 66,285 102,341 136,572 213,774
Segment operating (loss) income:        
Total segment operating loss (222,945) (184,151) (400,947) (399,896)
Operating expenses not allocated to segments:        
Stock-based compensation     77,928 134,474
Depreciation and amortization     30,199 36,610
Restructuring charges 17,066 0 17,066 0
Employer payroll taxes 1,100 1,000 2,700 3,200
Goodwill impairment 47,858 0 47,858 0
Lab equipment        
Operating expenses not allocated to segments:        
Impairment expense   9,000    
Corporate, Non-Segment        
Operating expenses not allocated to segments:        
Stock-based compensation 38,226 62,477 80,623 137,677
Depreciation and amortization 17,330 17,652 30,199 36,610
Impairment expense 47,858 9,001 47,858 9,001
Restructuring charges 17,066 0 17,066 0
Change in fair value of contingent consideration liability 3,211 3,276 2,284 8,453
Cell Engineering and Biosecurity        
Revenue:        
Total revenue 56,206 80,568 94,150 161,270
Segment research and development expense:        
Total segment research and development expense 96,945 86,611 197,166 185,700
Segment general and administrative expense:        
Total segment general and administrative expense 44,794 67,606 96,978 143,254
Cell Engineering and Biosecurity | Operating Segments        
Segment operating (loss) income:        
Total segment operating loss (99,254) (91,745) (222,917) (208,155)
Cell Engineering        
Revenue:        
Total revenue 36,205 45,283 64,094 79,379
Segment cost of revenue:        
Total segment cost of revenue 1,914 0 1,914 0
Segment research and development expense:        
Total segment research and development expense 96,487 86,083 196,588 184,605
Segment general and administrative expense:        
Total segment general and administrative expense 33,615 50,907 73,848 112,599
Segment operating (loss) income:        
Total segment operating loss (95,811) (91,707) (208,256) (217,825)
Biosecurity        
Revenue:        
Total revenue 20,001 35,285 30,056 81,891
Segment cost of revenue:        
Total segment cost of revenue 11,807 18,096 21,009 40,471
Segment research and development expense:        
Total segment research and development expense 458 528 578 1,095
Segment general and administrative expense:        
Total segment general and administrative expense 11,179 16,699 23,130 30,655
Segment operating (loss) income:        
Total segment operating loss $ (3,443) $ (38) $ (14,661) $ 9,670